Coen Steven P. 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Oct 21, 2025
Insider Transaction Report
Form 4
Coen Steven P.
See remarks
Transactions
- Exercise/Conversion
Class A Common Stock
2025-10-16+312→ 6,989 total - Exercise/Conversion
Restricted Stock Units
2025-10-16−1,174→ 11,166 total→ Class A Common Stock (1,174 underlying) - Exercise/Conversion
Class A Common Stock
2025-10-16+1,061→ 8,050 total - Exercise/Conversion
Restricted Stock Units
2025-10-16−312→ 4,535 total→ Class A Common Stock (312 underlying) - Exercise/Conversion
Class A Common Stock
2025-10-16+1,174→ 6,677 total - Sale
Class A Common Stock
2025-10-17$13.65/sh−1,312$17,907→ 6,738 total - Exercise/Conversion
Restricted Stock Units
2025-10-16−1,061→ 1,062 total→ Class A Common Stock (1,061 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
- [F3]The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
- [F4]The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
- [F5]The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026.